A report by the Congressional Budget Office concludes the Supreme Court’s ruling on the Affordable Care Act is likely to result in an increase in the number of uninsured Americans.
A new study finds about one in 10 U.S. employers say they plan to cut health coverage for workers over the next several years, as the bulk of health care reform regulations are implemented.
A new study finds a growing number of workers who get hurt on the job are getting their medication directly from their physicians, instead of pharmacies, which is driving up costs.
The demand for addiction treatment is high. The supply of addiction specialists is comparatively low. Yet unlike traditional economic models where money is the obstacle, in our field, the obstacle is time explains Dr. Stuart Gitlow, member of the AMA’s Council on Science & Public Health, and Acting President of the ASAM.
In one neonatal intensive care unit in Tennessee, almost half of the babies are going through withdrawal from prescription pills, ABC News reports.
An Ohio law that recently went into effect in Ohio allows families to seek involuntary addiction treatment for a loved one—if the family agrees to pay for it.
The U.S. Supreme Court’s decision last month on the Affordable Care Act is a victory for people with substance use disorder and mental health needs, according to the Legal Action Center, an advocacy group that provides legal assistance to people in recovery or still suffering from addiction. But much work remains to be done at the state level to assure adequate coverage, the group says.
Physicians and other prescribers will not be required to take educational courses under a new government plan aimed at reducing prescription drug abuse. The Wall Street Journal reports the plan does compel the makers of extended-release painkillers to fund courses for doctors and provide safety information to patients.
The U.S. Supreme Court’s decision to uphold the constitutionality of the Affordable Care Act is extremely uplifting for the substance abuse field, according to A. Thomas McLellan, PhD, CEO of the Treatment Research Institute and former Deputy Director of the White House Office of National Drug Control Policy.
Three current members of the U.S. House, joined by two former members, argued this week that health insurers are trying to take advantage of customers by decreasing coverage of mental health and addiction treatment.